Leishmania major: Antileishmanial Activity of Methylbenzethonium Chloride

J. El-OnDepartment of Microbiology and Immunology, Faculty of Health Sciences, Ben Gurion University of the Negev, Laboratory for Electron Microscopy, Tel Aviv Medical Center, Beer Sheva, Israel

Search for other papers by J. El-On in
Current site
Google Scholar
PubMed
Close
and
G. MesserDepartment of Microbiology and Immunology, Faculty of Health Sciences, Ben Gurion University of the Negev, Laboratory for Electron Microscopy, Tel Aviv Medical Center, Beer Sheva, Israel

Search for other papers by G. Messer in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

Methylbenzethonium chloride (MBCl) decreased the growth of Leishmania major promastigotes and amastigotes in vitro. This decrease occurred during 4 days of exposure to the drug at concentrations of 0.1 to 2.5 µg ml-1. MBCl at 2 µg ml-1 killed almost 100% of the free living promastigotes and 87% of amastigotes within 4 days of treatment. Electron microscopy studies showed marked swelling of mitochondria in treated parasites. A possible additional effect on the parasite surface membrane is discussed.

Save